Uploaded July 2026 | Updated September 2026, 2 weeks ago
🩸 Blood Oxygen App: apps.apple.com/us/app/o-buddy-blood-oxygen/id6751239297
Apple just lost a major patent fight. A federal judge upheld a $634 million jury verdict after ruling that the Apple Watch qualifies as a "patent monitor" — the exact term Apple argued should only apply to hospital-grade medical equipment. In this video I break down the full Apple vs. Masimo timeline, from the original 2020 trade-secrets lawsuit and the 2023 International Trade Commission import ban, to the December 2023 sales pause on the Series 9 and Ultra 2, Apple's clever August 2025 workaround that moved blood oxygen processing to the iPhone, and the November 2025 jury verdict over heart rate monitoring. Judge Selna denied both of Apple's motions — one to overturn the verdict and one for a new trial — so Apple is now headed to the Federal Circuit on appeal.
00:00:00 Apple Loses in Court
00:00:43 How the Masimo Fight Started (2020)
00:01:08 The 2023 ITC Import Ban
00:01:57 Watches Sold Without the Sensor
00:02:23 Apple's Genius Workaround
00:03:06 The $634 Million Verdict
00:03:46 What It Means for Your Watch Today
00:04:06 O2 Buddy App Demo
00:06:32 What "Patent Monitor" Really Means
00:07:14 How Apple's Marketing Backfired
00:10:20 Apple's Statement & Appeal
00:11:18 When Blood Oxygen Comes Back
#applewatch #bloodoxygen #applelawsuit
===================================================
🎥 YouTube Gear: brianminor.com/links/youtube-gear
đź’» Office Setup: brianminor.com/links/office
Follow me elsewhere:
instagram.com/theapplebias
Visit my site: applebias.com
* Most of the links above are affiliate links. If you click on them before making a purchase, it will help support the channel. However, please don’t feel obligated to make a purchase. Simply watching my video means the world to me.
🩸 Blood Oxygen App: apps.apple.com/us/app/o-buddy-blood-oxygen/id6751239297
Apple just lost a major patent fight. A federal judge upheld a $634 million jury verdict after ruling that the Apple Watch qualifies as a "patent monitor" — the exact term Apple argued should only apply to hospital-grade medical equipment. In this video I break down the full Apple vs. Masimo timeline, from the original 2020 trade-secrets lawsuit and the 2023 International Trade Commission import ban, to the December 2023 sales pause on the Series 9 and Ultra 2, Apple's clever August 2025 workaround that moved blood oxygen processing to the iPhone, and the November 2025 jury verdict over heart rate monitoring. Judge Selna denied both of Apple's motions — one to overturn the verdict and one for a new trial — so Apple is now headed to the Federal Circuit on appeal.
00:00:00 Apple Loses in Court
00:00:43 How the Masimo Fight Started (2020)
00:01:08 The 2023 ITC Import Ban
00:01:57 Watches Sold Without the Sensor
00:02:23 Apple's Genius Workaround
00:03:06 The $634 Million Verdict
00:03:46 What It Means for Your Watch Today
00:04:06 O2 Buddy App Demo
00:06:32 What "Patent Monitor" Really Means
00:07:14 How Apple's Marketing Backfired
00:10:20 Apple's Statement & Appeal
00:11:18 When Blood Oxygen Comes Back
#applewatch #bloodoxygen #applelawsuit
===================================================
🎥 YouTube Gear: brianminor.com/links/youtube-gear
đź’» Office Setup: brianminor.com/links/office
Follow me elsewhere:
instagram.com/theapplebias
Visit my site: applebias.com
* Most of the links above are affiliate links. If you click on them before making a purchase, it will help support the channel. However, please don’t feel obligated to make a purchase. Simply watching my video means the world to me.
